Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1179475

Hussman Strategic Advisors, Inc.

Mutual fund managerFiled 2026-08-03 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$434.0M
Reported positions
231
Top holdings a year, 3 yrs
+32.1%
Assets under management
$617.4M

Hussman Strategic Advisors, Inc. is a mutual fund manager that reported 231 positions worth $434.0M in its Q2 2026 13F, filed 2026-08-03. Its largest holdings were Pepsico Inc (PEP, 1.2%), Ubiquiti Inc (UI, 1.2%), Incyte Corp (INCY, 1.1%). A portfolio copying its top holdings returned 32.1% a year over the last 3 years, against 20.4% for the S&P 500.

Hussman Strategic Advisors, Inc. holdings largest 50 of 231 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Hussman Strategic Advisors, Inc. 13F holdings
Stock% of 13F valueShare changeReported value
PEPPepsico Inc1.2%—$5.1M
UIUbiquiti Inc1.2%+125.0%$5.0M
INCYIncyte Corp1.1%+33.3%$4.8M
VSATViasat Inc Com1.1%-28.6%$4.7M
NBIXNeurocrine Biosciences Inc1.1%+30.0%$4.6M
BIIBBiogen Inc1.0%—$4.5M
HSYHershey Co1.0%—$4.4M
CMPRCimpress PLC1.0%—$4.3M
JCOMZiff Davis Inc0.9%—$3.8M
UNFIUnited Nat Foods Inc0.9%-20.0%$3.8M
ULTAUlta Beauty Inc0.9%+14.3%$3.8M
CPBThe Campbells Company0.9%-20.0%$3.7M
GISGeneral Mills Inc0.8%—$3.7M
TDCTeradata Corp Del0.8%—$3.6M
DGDollar Gen Corp0.8%+0.0%$3.6M
AEOAmerican Eagle Outfitters in0.8%+0.0%$3.6M
PACSPacs Group Inc0.8%—$3.6M
AUPHAurinia Pharmaceuticals Inc0.8%—$3.6M
SHOOMadden Steven Ltd0.8%+0.0%$3.5M
PFSProvident Finl Svcs Inc0.8%—$3.5M
PRLBProto Labs Inc0.8%-20.0%$3.4M
APAApa Corporation0.8%+0.0%$3.4M
NEMNewmont Corp0.8%—$3.4M
BBarrick Mng Corp0.8%—$3.4M
MCYMercury General Corp0.8%—$3.4M
MEDPMedpace Hldgs Inc0.8%+0.0%$3.3M
TRTootsie Roll Inds Inc0.8%+29.4%$3.3M
GMEDGlobus Med Inc0.8%—$3.3M
CRMSalesforce Inc0.8%—$3.3M
HALOHalozyme Therapeutics Inc0.8%-20.0%$3.3M
OZKBank Ozk Little Rock Ark Com0.8%—$3.3M
REGNRegeneron Pharmaceuticals0.8%—$3.3M
MTCHMatch Group Inc.0.7%—$3.2M
ETSYEtsy Inc0.7%-50.0%$3.2M
VCVisteon Corp Com New0.7%+0.0%$3.1M
YETIYeti Hldgs Inc0.7%—$3.1M
HCSGHealthcare Svcs Group Inc0.7%-25.0%$3.1M
AMGNAmgen Inc0.7%—$3.0M
NXTNextpower Inc0.7%—$3.0M
GOOGLAlphabet Inc0.7%—$3.0M
TET1 Energy Inc0.7%—$3.0M
INBXInhibrx Biosciences Inc0.7%—$3.0M
AKAMAkamai Technologies Inc0.7%—$3.0M
URBNUrban Outfitters Inc0.7%—$3.0M
MMacy's Inc0.7%—$3.0M
ADSBread Financial Holdings Inc0.7%—$3.0M
AMRCAmeresco Inc0.7%-16.7%$2.9M
TGTXTG Therapeutics Inc0.7%—$2.9M
AEMAgnico Eagle Mines Ltd0.7%—$2.8M
LEALear Corp0.6%—$2.8M

What Hussman Strategic Advisors, Inc. bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Added to

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
+55.4% /yr
S&P 500 +20.1%
3 years
+32.1% /yr
S&P 500 +20.4%
5 years
+21.9% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$434.0M231
Q1 2026$462.5M268
Q4 2025$413.7M252
Q3 2025$461.8M270
Q2 2025$437.6M210
Q1 2025$412.6M232
Q4 2024$338.5M234
Q3 2024$407.1M216
Q2 2024$363.0M232
Q1 2024$430.0M216
Q4 2023$439.9M222
Q3 2023$523.9M296

Questions about Hussman Strategic Advisors, Inc.'s portfolio

What stocks does Hussman Strategic Advisors, Inc. own?

Hussman Strategic Advisors, Inc.'s latest 13F, for Q2 2026 and filed Aug 3, 2026, lists 231 positions worth $434.0M. The largest are Pepsico Inc (PEP) at 1.2%, Ubiquiti Inc (UI) at 1.2%, Incyte Corp (INCY) at 1.1%, Viasat Inc Com (VSAT) at 1.1% and Neurocrine Biosciences Inc (NBIX) at 1.1%.

What did Hussman Strategic Advisors, Inc. buy last quarter?

In Q2 2026, Hussman Strategic Advisors, Inc. added Ubiquiti Inc (UI) (+125.0% shares), Incyte Corp (INCY) (+33.3% shares) and Neurocrine Biosciences Inc (NBIX) (+30.0% shares), compared with its Q1 2026 filing.

What did Hussman Strategic Advisors, Inc. sell last quarter?

In Q2 2026, Hussman Strategic Advisors, Inc. cut from its top 50 Corcept Therapeutics Inc (CORT), cut from its top 50 Ani Pharmaceuticals Inc (ANIP), cut from its top 50 Concentrix Corp (CNXC), cut from its top 50 Sezzle Inc. (SEZL), cut from its top 50 Power Solutions Intl Inc (PSIX), Etsy Inc (ETSY) (-50.0% shares), Viasat Inc Com (VSAT) (-28.6% shares) and Healthcare Svcs Group Inc (HCSG) (-25.0% shares), compared with its Q1 2026 filing.

How has Hussman Strategic Advisors, Inc.'s portfolio performed?

A portfolio copying Hussman Strategic Advisors, Inc.'s 20 largest 13F holdings each quarter, from the day each filing was public, returned +32.1% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +55.4% against +20.1%. Over 5 years: +21.9% a year against +11.6%.

When is Hussman Strategic Advisors, Inc.'s next 13F filing due?

13F filings are due 45 days after each quarter ends. Hussman Strategic Advisors, Inc.'s filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Hussman Strategic Advisors, Inc. manage?

Hussman Strategic Advisors, Inc. reported $617.4M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $434.0M.